by What is the Blood Group Typing Market Size in 2026?
The global blood group typing market size was valued at USD 2.42 billion in 2025 and is projected to grow from USD 2.63 billion in 2026 to approximately USD 5.52 billion by 2035, expanding at a CAGR of 8.60% from 2026 to 2035. The market growth is primarily driven by the increasing demand for safe blood transfusions, rising prevalence of chronic diseases, and advancements in blood typing technologies.
Read Also: S1P Receptor Modulator Drugs Market
Blood Group Typing Market Key Takeaways
- North America dominated the market with a 38% share in 2025
- Asia Pacific is expected to grow at the fastest CAGR during the forecast period
- By product, the kits segment held the largest share of 48% in 2025
- The instruments segment is projected to grow at the fastest CAGR of 7.4%
- By technology, serological/immunohematology dominated with 52% share
- The molecular/genotyping segment is expected to grow at the highest CAGR of 7.6%
- By end user, hospitals & clinics led with 44% market share
- By application, the transfusion segment dominated with 45% share
Market Overview
Blood group typing refers to the identification of an individual’s blood type, primarily through the ABO and Rh systems, which is critical for safe blood transfusions and medical procedures. The market includes a wide range of technologies such as serological testing, molecular diagnostics, and automated blood typing systems.
The increasing demand for blood transfusions due to rising surgical procedures, trauma cases, cancer treatments, and chronic conditions such as anemia is significantly fueling market growth. Additionally, advancements in laboratory automation and digital healthcare infrastructure are enhancing the speed, accuracy, and reliability of blood typing processes.
How is AI Influencing the Blood Group Typing Market?
Artificial Intelligence (AI) is revolutionizing the blood group typing market by improving accuracy, efficiency, and scalability.
- AI algorithms help automate complex serological and molecular data analysis, reducing human error
- Enables high-throughput testing, essential for hospitals and blood banks handling large sample volumes
- Supports real-time data integration with laboratory information systems
- Enhances identification of rare blood group antigens
AI integration is particularly beneficial in improving patient safety and ensuring precise donor-recipient matching in transfusion procedures.
Blood Group Typing Market Trends
1. Increasing Adoption of Automation
Hospitals and blood banks are adopting automated systems to improve testing speed, reduce manual errors, and handle large sample volumes efficiently.
2. Growing Use of Molecular Techniques
Molecular and genotyping technologies are gaining traction due to their ability to detect rare and complex blood group antigens with high accuracy.
3. Integration with Digital Health Systems
The integration of Laboratory Information Management Systems (LIMS) enhances workflow efficiency, traceability, and compliance.
4. Expansion in Emerging Markets
Rapid healthcare infrastructure development in Asia-Pacific and Latin America is boosting the adoption of advanced blood typing technologies.
5. Advancements in Genomic Technologies
Technologies such as PCR, microarrays, and next-generation sequencing (NGS) are transforming blood typing by enabling precise and comprehensive analysis.
Market Scope
| Report Coverage | Details |
|---|---|
| Market Size in 2025 | USD 2.42 Billion |
| Market Size in 2026 | USD 2.63 Billion |
| Market Size by 2035 | USD 5.52 Billion |
| Growth Rate | CAGR of 8.60% |
| Base Year | 2025 |
| Forecast Period | 2026–2035 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
Segment Insights
Product Insights
Why Did the Kits Segment Dominate the Market?
The kits segment held a dominant share of 48% in 2025 due to its cost-effectiveness, ease of use, and wide applicability in hospitals, blood banks, and diagnostic laboratories. These kits enable rapid and accurate testing without requiring complex infrastructure.
Fastest Growing Segment: Instruments
The instruments segment is expected to grow at the fastest rate due to increasing adoption of automated blood typing systems. These systems offer higher precision, faster turnaround times, and the ability to process large volumes efficiently.
Technology Insights
Serological/Immunohematology Segment Dominance
The serological/immunohematology segment led the market with a 52% share in 2025, owing to its reliability, affordability, and widespread use in clinical settings.
Molecular/Genotyping Segment Growth
The molecular/genotyping segment is projected to grow rapidly due to its ability to identify rare and complex blood group antigens with high accuracy. Integration with AI and digital systems further enhances its efficiency.
End User Insights
Hospitals & Clinics Leadership
The hospitals & clinics segment accounted for the largest share due to high volumes of transfusion-related procedures, surgeries, and emergency care services.
Diagnostic Laboratories Growth
The diagnostic laboratories segment is expected to grow significantly due to increasing demand for specialized and high-throughput testing services.
Application Insights
Transfusion Segment Dominance
The transfusion segment held the largest share of 45% in 2025, driven by its critical role in surgeries, trauma care, and chronic disease management.
Research & Drug Development Growth
The research & drug development segment is expected to expand rapidly due to increasing use of blood typing in clinical trials, pharmaceutical research, and personalized medicine.
Regional Insights
North America Market Trends
North America dominated the market due to:
- Advanced healthcare infrastructure
- High adoption of automated and molecular technologies
- Strong regulatory frameworks and patient safety standards
- Increasing prevalence of chronic diseases
The U.S. remains a key contributor due to high demand for advanced diagnostic solutions and continuous technological innovation.
Asia Pacific Market Growth
Asia Pacific is expected to grow at the fastest rate due to:
- Expanding healthcare infrastructure
- Rising awareness of safe blood transfusion practices
- Increasing number of hospitals and diagnostic laboratories
- Growing demand for advanced diagnostic technologies
Countries like India, China, and Japan are driving regional growth.
Competitive Landscape
Key players operating in the blood group typing market include:
- Abbott Laboratories
- Bio-Rad Laboratories
- Ortho Clinical Diagnostics
- Grifols S.A.
- Immucor Inc.
- Siemens Healthineers
- Terumo Corporation
- Quotient Limited
- DIAGAST
- Werfen
These companies focus on innovation, automation, and advanced molecular technologies to strengthen their market position.
Recent Developments
- June 2025: Devyser launched an advanced genomic blood typing solution based on next-generation sequencing (NGS).
- May 2024: Thermo Fisher Scientific introduced a high-throughput blood genotyping array capable of detecting over 260 antigens across multiple blood group systems.
Conclusion
The blood group typing market is poised for strong growth, driven by rising demand for safe transfusion practices, technological advancements, and increasing healthcare investments. The integration of AI, automation, and molecular diagnostics is transforming the industry, enabling faster, more accurate, and scalable blood typing solutions.
Companies investing in innovation, digital integration, and advanced diagnostic technologies will gain a competitive edge in this rapidly evolving market.
Get Sample Copy: https://www.precedenceresearch.com/sample/8146
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
- Endoscope Reprocessing Chemicals Market Size to Hit USD 2.06 Billion by 2035 - March 27, 2026
- Particle Therapy Market Size to Hit USD 3.92 Billion by 2035 - March 27, 2026
- Blood Group Typing Market Size to Hit USD 5.52 Billion by 2035 - March 27, 2026
